News Update

Newsletter

May 7, 2019

 
 
 

New Strategic Research and Innovation Agenda on Antimicrobial Resistance

The JPIAMR Strategic Research and Innovation Agenda (SRIA) that was published today presents an overview of recent developments and future needs for AMR research. The SRIA outlines six key priority topics within the AMR field: Therapeutics, Diagnostics, Surveillance Transmission, Environment and Interventions, and has defined a set of research objectives within each priority topic. Together, 27 countries has created the SRIA.

The SRIA highlights many important research needs, including:

The need to address AMR with a holistic One Health approach
The necessity of including innovation in every aspect of AMR research
Increased inclusion of low and middle income countries (LMIC)
The need for developments incorporating personalised medicine and artificial intelligence.

 

The SRIA is a prime guiding tool for AMR research prioritisation in investments, research activities and planning for JPIAMR member states and other funding initiatives. It is also one of the most thorough guidelines on AMR research, helping researchers, policy makers, media, educators, health workers and the scientific community to work together on solutions to curb AMR on a global scale.

Read more on the JPIAMR SRIA on the JPIAMR website

Download the JPIAMR SRIA (60 pages)

Download an overview of JPIAMR SRIA priority topics and research and innovation objectives (2 pages)

 
Follow us!
Facebook Twitter
 

Joint Programming Initiative on Antimicrobial Resistance
secretariat.jpiamr@vr.se
Visit our website
Unsubscribe

 
Share to
Facebook Twitter LinkedIn